Респираторная медицина. Руководство (в 2-х томах)

Чучалин А. Г.

63.Ng T.P., Niti M., Tan W.C., et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life // Arch. Intern. Med. 2007. V. 167. 1. P. 60-67.

64.Olafsson S., Johnson E. An alcohol addict with chronic obstructive lung disease and hematemesis. // Tidsskr. Nor. Laegeforen. 2004. V .124. 9. P. 1243-1244.

65.Ortapamuk H., Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment // Ann. Nucl. Med. 2006. V. 20. 2. P. 99-106.

66.Orth M., Kotterba S., Duchna K., et al. Cognitive deficits in patients with chronic obstructive pulmonary disease (COPD) // Pneumologie. 2006. V. 60. 10. P. 593-599.

67.Ozge C., Ozge A., Unal O. Cognitive and functional deterioration in patients with severe COPD // Behav. Neurol. 2006. V. 17. 2. P. 121-130.

68.Rietveld S., Beest I. van, Prins PJ. The relationship between specific anxiety syndromes and somatic symptoms in adolescents with asthma and other chronic diseases // J. Asthma. 2005. V. 42. 9. P. 725-730.

69.Ross C.J., Davis T.M., Hogg D.Y. Screening and assessing adolescent asthmatics for anxiety disorders // Clin. Nurs. Res. 2007. V.16. 1. P. 5-24.

70.Sabaawi M., Gutierrez-Nunez J., Fragala M.R. Neurosarcoidosis presenting as schizophreniform disorder // Int. J. Psychiatry Med. 1992. V. 22. P. 269-274.

71.Sanderson Cox L., Patten C.A., Ebbert J.O. et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence // J. Clin. Oncol. 2002. V. 20. 16. P. 3461-3469.

72.Scheschonka A., Bleich S., Buchwald A.B. et al. Development of obsessive-compulsive behaviour following cortisone treatment // Pharmacopsychiatry. 2002. V. 35. 2. P.72-74.

73.Schmaling K.B., Bell J. Asthma and Panic Disorder // Arch. Fam. Med. 1997. V. 6. P. 20-23.

74.Shavitt R.G., Gentil V., Mandetta R. The association of panic/agoraphobia and asthma. Contributing factors and clinical implications // Gen. Hosp. Psychiatry. 1992. V. 14. 6. P. 420-423.

75.Sietsema K.E., Simon J.I., Wasserman K. Pulmonary hypertension presenting as a panic disorder // Chest. 1987. V. 91. 6. P. 910-912.

76.Slowik-Gabryelska A. Analysis of circumstances of the development of chronic bronchitis in patients treated at Bydgoszcz Lung Disease Clinic in 1993-1996 // Pol. Merkuriusz. Lek. 1998. V. 5. 30. P. 321-324.

77.Stage K.B., Middelboe T., Pisinger C. Depression and chronic obstructive pulmonary disease (COPD). Impact on survival // Acta Psychiatr. Scand. 2005. V. 111. 4. P. 320-323.

78.Strauss D.H. Spitzer R.L., Muskin P.R. Maladaptive denial of the illness // Am. J. Psychiat. 1990. V. 147. 9. P. 1168 - 1172.

79.Sugihara H., Ishihara K. Noguchi H. Clinical experience with amitriptyline in the treatment of bronchial asthma // Ann. Allergy 1965. V. 23. P. 422-429.

80.Tabak C., Smit H.A., Rasanen L., et al. Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries. // Epidemiology. 2001. V. 12. 2. P. 239-245.

81.Takakura M., Wake N. Association of age at onset of cigarette and alcohol use with subsequent smoking and drinking patterns among Japanese high school students // J. Sch. Health. 2003. V. 73. 6. P. 226-231.

82.Thomas M., McKinley R.K., Freeman E., et al. Prevalence of dysfunctional breathing in patients treated for asthma in primary care // BMJ 2001. V. 322. P. 1098-1100.

83.Tolle R. Somatopsychic aspects of paranoia //Psychopatology. 1993. V. 26. P. 127-137.

84.Turner - Warwick M. On observing patterns of airflow obstruction in chronic asthma // Br. J. Dis. Chest. 1977. V. 71. P. 73 - 86.

85.Uchitomi Y., Mikami I., Nagai K., et al. Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer // J. Clin. Oncol. 2003. V. 21. 1. P. 69-77.

86.Valenca A.M., Falcao R., Freire R.C., et al. The relationship between the severity of asthma and comorbidities with anxiety and depressive disorders // Rev. Bras. Psiquiatr. 2006. V. 28. 3. P.206-208.

87.Vega P., Sweetland A., Acha J., et al. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis // Int. J. Tuberc. Lung Dis. 2004. V. 8. 6. P.749-759.

88.Wadland W.C, Ferenchick G.S. Medical comorbidity in addictive disorders // Psychiatr. Clin. North Am. 2004. V. 27. 4. P. 675-687.

89.Wagena E.J., Huibers M.J., Schayck C.P. van. Therapies for smoking cessation (antidepressants, nicotine-replacement and counseling) and implications for the treatment of patients with chronic obstructive pulmonary disease // Ned. Tijdschr. Geneeskd. 2001. V. 145. 31. P. 1492-1496.

90.Yellowiees, P. M., Kalucy R. S.. Psychobiological aspects of asthma and the consequent research implications // Chest. 1990. V. 97. P. 628-634.

91.Yellowlees P.M., Haynes S., Potts N., et al. Psychiatric morbidity in patients with life-threatening asthma: initial report of a controlled study // Med. J. Aust. 1988. V. 149. P. 246-249.

92.Yellowlees. P. M. The treatment of psychiatric disorders in patients with chronic airways obstruction // Med. J. Aust. 1987. V. 147. P. 349-352.

document:

$pr:

version: 01-2007.1

codepage: windows-1251

type: klinrek

id: kli18195336

: 16.1.

ВИЧ-ИНФЕКЦИЯ В СОЧЕТАНИИ С ТУБЕРКУЛЕЗОМ

meta:

author:

fio[ru]: А.А. Приймак, А.С. Свистунова

codes:

next: